Royce & Associates LP Enovis Corp Transaction History
Royce & Associates LP
- $8.75 Billion
- Q1 2025
A detailed history of Royce & Associates LP transactions in Enovis Corp stock. As of the latest transaction made, Royce & Associates LP holds 2,490,806 shares of ENOV stock, worth $67.7 Million. This represents 1.09% of its overall portfolio holdings.
Number of Shares
2,490,806
Previous 2,470,576
0.82%
Holding current value
$67.7 Million
Previous $109 Million
12.29%
% of portfolio
1.09%
Previous 1.06%
Shares
13 transactions
Others Institutions Holding ENOV
# of Institutions
319Shares Held
63.7MCall Options Held
1.67MPut Options Held
473K-
T. Rowe Price Investment Management, Inc. Baltimore, MD6.21MShares$169 Million0.16% of portfolio
-
Vanguard Group Inc Valley Forge, PA6.11MShares$166 Million0.0% of portfolio
-
Black Rock Inc. New York, NY5.43MShares$148 Million0.01% of portfolio
-
American Century Companies Inc Kansas City, MO3.52MShares$95.8 Million0.09% of portfolio
-
Dimensional Fund Advisors LP Austin, TX2.93MShares$79.6 Million0.03% of portfolio
About Enovis CORP
- Ticker ENOV
- Exchange NYSE
- Sector Industrials
- Industry Specialty Industrial Machinery
- Shares Outstandng 54,129,500
- Market Cap $1.47B
- Description
- Enovis Corporation operates as a medical technology company worldwide. It develops, manufactures, and distributes medical device products used by orthopedic specialists, surgeons, primary care physicians, pain management specialists, physical therapists, podiatrists, chiropractors, athletic trainers, and other healthcare professionals to treat p...